This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1996 Aug 1;94(3):240-3.

doi: 10.1161/01.cir.94.3.240.

Reversing endothelial dysfunction with ACE inhibitors. A new trend

S Rajagopalan, D G Harrison

PMID: 8759059
DOI: 10.1161/01.cir.94.3.240

Editorial

Reversing endothelial dysfunction with ACE inhibitors. A new trend

S Rajagopalan et al. Circulation. 1996.

. 1996 Aug 1;94(3):240-3.

doi: 10.1161/01.cir.94.3.240.

Authors

S Rajagopalan, D G Harrison

PMID: 8759059
DOI: 10.1161/01.cir.94.3.240

No abstract available

PubMed Disclaimer

Comment on

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Lüscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B. Mancini GB, et al. Circulation. 1996 Aug 1;94(3):258-65. doi: 10.1161/01.cir.94.3.258. Circulation. 1996. PMID: 8759064 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Miscellaneous
- NCI CPTAC Assay Portal